0.00Open0.00Pre Close0 Volume0 Open Interest16.00Strike Price0.00Turnover107.90%IV-6.43%PremiumDec 20, 2024Expiry Date1.10Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.6956Delta0.1319Gamma10.21Leverage Ratio-0.0645Theta0.0021Rho7.10Eff Leverage0.0086Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet